ArticleThe Lancet regional health. Western Pacific2026
Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Jingyun Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.